Back to search
FDAFDA · Food and drugs·Recall number D-0676-2026

Cinacalcet Hydrochloride Tablets, 90 mg, 30-count bottle, Rx Only, Manufactured by: Cipla Ltd., MIDC, Patalganga, India; Manufactured for: Cipla USA, Inc., 10 Independence Boulevard, Suite 300, Warren, NJ 07059, NDC 69097-412-02

Published July 8, 2026 · Recall initiated: June 29, 2026

Summary

FDA records drug Class II recall D-0676-2026, published July 8, 2026 and initiated June 29, 2026. Recalling firm: Cipla USA, Inc.; Status: Ongoing; Reported quantity: N/A; Lot: Lot #: 5PB0563, Exp 4/30/2027. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

cGMP Deviations: presence of N-nitroso-cinacalcet, above the acceptable daily intake (ADI).

What to do

Voluntary: Firm initiated · Letter

Get an email if CINACALCET has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
CINACALCET
Manufacturer
Cipla USA, Inc.
Distributor
USA Nationwide
Lot
Lot #: 5PB0563, Exp 4/30/2027
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Cinacalcet Hydrochloride Tablets, 90 mg, 30-count bottle, Rx Only, Manufactured by: Cipla Ltd., MIDC, Patalganga, India; Manufactured for: Cipla USA, Inc., 10 Independence Boulevard, Suite 300, Warren, NJ 07059, NDC 69097-412-02 recalled?

Yes. FDA published recall D-0676-2026 on July 8, 2026. Reported hazard: cGMP Deviations: presence of N-nitroso-cinacalcet, above the acceptable daily intake (ADI).

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: CINACALCET.